< Back to search trials

A Phase 2, Open-Label, Single-Arm, Multi-Center Study Of AL101 (BMS-906024) In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations

  • Clinicaltrials.gov #: NCT03691207
  • Acronym: AL-ACC-01 / ACCURACY
  • Tumor Type: Head & Neck
  • Tumor Subtype: N/A
  • Tumor Stage: N/A
  • Type of Treatment: